| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $331.16K | $734.80K | $1.69M | $2.04M | – |
| Operating Income | -$461.00K | -$943.15K | -$1.89M | -$2.24M | -$2.08M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $17.32K | $122.76K | $218.29K | $207.63K | $0.00 |
| Net Income | -$344.79K | -$408.11K | -$814.49K | -$1.24M | -$1.88M |
| EPS (basic) | -0.0500 | -0.0600 | -0.1000 | -0.0800 | -0.1200 |
| EPS (diluted) | -0.0500 | -0.0600 | -0.1000 | -0.0800 | -0.1200 |
| Shares (diluted) | $6.86M | $7.36M | $8.25M | $15.29M | $15.19M |